Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-04-18

FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for lansoprazole, authorizing the marketing of a generic lansoprazole product in the Unit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lansoprazole (Lansoprazole)

Snippet

SUPPL AP for LANSOPRAZOLE (LANSOPRAZOLE)